Costs of Additional Cover
نویسندگان
چکیده
منابع مشابه
Bronchiolitis obliterans syndrome and additional costs of lung transplantation.
STUDY OBJECTIVES The influence of bronchiolitis obliterans syndrome (BOS) on costs after lung transplantation was investigated by comparing the costs of patients with and without this condition. DESIGN Follow-up costs were prospectively investigated in a medical technology assessment of the Dutch Lung Transplant Program, in relation to the development of the BOS. First, average follow-up cost...
متن کاملReplicated Parallel I/O without Additional Scheduling Costs
A common technique for improving performance in a database is to decluster the database among multiple disks so that data retrieval can be parallelized. In this paper we focus on answering range queries in a multidimensional database (such as a GIS), where each of its dimensions is divided uniformly to obtain tiles which are placed on different disks; there has been a significant amount of rese...
متن کاملEstimation of the additional costs of chemotherapy for patients with advanced non-small cell lung cancer.
BACKGROUND A large multicentre randomised trial, the Big Lung Trial, which in part compared supportive care with or without cisplatin-based chemotherapy in patients with advanced non-small cell lung cancer, provided an opportunity to evaluate the impact on the UK National Health Service of the costs incurred with the use of chemotherapy. METHODS This costing study was based on the retrospecti...
متن کاملOn the Choice of Royalty Rule to Cover Fixed Costs in Input Joint Ventures
In a model where two competing downstream firms establish an input joint venture (JV), we analyze how different royalty rules for covering fixed costs affect channel profits. Under running royalties (regardless of whether based on predicted or actual output), the downstream firms’ perceived marginal costs are above the true marginal costs since fixed costs are incorporated. We find that tougher...
متن کاملCosts and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation.
BACKGROUND Cytomegalovirus (CMV) disease is one of the major challenges of lung transplantation that may determine outcome. The benefits of ganciclovir prophylaxis seem indisputable, but no consensus has been reached on the optimal duration of therapy. Results with different protocols suggest that efficacy is related to the duration of treatment. MATERIALS AND METHODS To evaluate the addition...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Annals of The Royal College of Surgeons of England
سال: 2008
ISSN: 0035-8843,1478-7083
DOI: 10.1308/003588408x321576